New SwiftArrayStudio analyzer and updated genotyping arrays deliver results in as little as 30 hours, enabling researchers to drive impactful, scalable genetic research Thermo Fisher Scientific, the ...
The research community's rapid acceptance of microarrays notwithstanding, technical challenges remain. Biochip developers continue to grapple with these issues while upgrading their offerings and ...
To understand how microarray technology is evolving to meet growing scientific demands, Technology Networks spoke with Thermo ...
The Global MiRNA Microarray Kits And Reagents Market is projected to grow at a CAGR of 8.5% from 2026 to 2033, according to a new report published by Verified Market Reports®. The report reveals that ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, announced today that the Applied Biosystems™ CytoScan™ Dx Assay and Applied Biosystems™ ...
Microarray image analysis has long been recognised as a pivotal methodology for quantifying gene expression across thousands of genes simultaneously. By converting intricate patterns of hybridised ...
Numerous studies have shown that homologous recombination deficiency (HRD) is a genome-wide biomarker present in high grade ovarian and breast cancers. A cancer therapeutic class, PARP inhibitors, ...
The MarketWatch News Department was not involved in the creation of this content. New SwiftArrayStudio analyzer and updated genotyping arrays deliver results in as little as 30 hours, enabling ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback